Total Payments
$3,034
2024 Payments
$596.55
Companies
18
Transactions
91
Medicare Patients
1,089
Medicare Billing
$206,452
Payment Breakdown by Category
Food & Beverage$2,261 (74.5%)
Travel$772.09 (25.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,261 | 89 | 74.5% |
| Travel and Lodging | $772.09 | 2 | 25.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relievant Medsystems, Inc. | $866.75 | 4 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $686.54 | 45 | $0 (2024) |
| Nevro Corp. | $516.71 | 10 | $0 (2024) |
| Medtronic, Inc. | $160.81 | 1 | $0 (2022) |
| Abbott Laboratories | $154.41 | 3 | $0 (2023) |
| PROTEGA PHARMACEUTIALS INC | $89.68 | 2 | $0 (2023) |
| SPR Therapeutics, Inc | $89.20 | 1 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $82.09 | 5 | $0 (2023) |
| ABBVIE INC. | $74.71 | 5 | $0 (2024) |
| Averitas Pharma Inc. | $67.96 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.55 | 24 | Collegium Pharmaceutical, Inc. ($248.44) |
| 2023 | $763.07 | 31 | Collegium Pharmaceutical, Inc. ($227.93) |
| 2022 | $1,661 | 35 | Relievant Medsystems, Inc. ($836.74) |
| 2021 | $12.90 | 1 | Gilead Sciences, Inc. ($12.90) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.68 | General |
| Category: Opioid Analgesic | ||||||
| 12/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Analgesic | ||||||
| 11/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.62 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/31/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $10.93 | General |
| Category: Opioid Analgesic | ||||||
| 09/20/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $73.25 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/05/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $135.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Opioid Analgesic | ||||||
| 08/29/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $25.57 | General |
| 08/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.77 | General |
| Category: Opioid Analgesic | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $8.02 | General |
| Category: Opioid Analgesic | ||||||
| 07/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.09 | General |
| Category: Opioid Analgesic | ||||||
| 06/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Opioid Analgesic | ||||||
| 06/06/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Opioid Analgesic | ||||||
| 05/08/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Opioid Analgesic | ||||||
| 04/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.63 | General |
| Category: Opioid Analgesic | ||||||
| 04/17/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Opioid Analgesic | ||||||
| 03/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Opioid Analgesic | ||||||
| 02/28/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Opioid Analgesic | ||||||
| 01/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: Opioid Analgesic | ||||||
| 12/21/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 514 | 1,506 | $530,981 | $101,983 |
| 2022 | 11 | 575 | 1,443 | $503,100 | $104,469 |
Total Patients
1,089
Total Services
2,949
Medicare Billing
$206,452
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 506 | $283,360 | $37,055 | 13.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 96 | 259 | $74,092 | $28,133 | 38.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 99 | 281 | $54,500 | $16,506 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 282 | $74,496 | $13,610 | 18.3% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 29 | 30 | $17,321 | $2,362 | 13.6% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 21 | 22 | $13,669 | $1,864 | 13.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 29 | $4,553 | $969.30 | 21.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 41 | 44 | $6,703 | $914.32 | 13.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 17 | 53 | $2,287 | $570.24 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 526 | $294,560 | $40,538 | 13.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 111 | 248 | $70,945 | $27,543 | 38.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 128 | 279 | $54,112 | $16,760 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 213 | $56,019 | $11,791 | 21.0% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 27 | 27 | $10,570 | $4,186 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $6,400 | $1,565 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $4,680 | $823.87 | 17.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 17 | $2,669 | $610.25 | 22.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 13 | 50 | $2,100 | $542.49 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 11 | $781.00 | $91.30 | 11.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 11 | 44 | $264.00 | $18.00 | 6.8% |
About Ashley May, APRN
Ashley May, APRN is a Family healthcare provider based in Cordova, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2016. The National Provider Identifier (NPI) number assigned to this provider is 1013463223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley May, APRN has received a total of $3,034 in payments from pharmaceutical and medical device companies, with $596.55 received in 2024. These payments were reported across 91 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,261).
As a Medicare-enrolled provider, May has provided services to 1,089 Medicare beneficiaries, totaling 2,949 services with total Medicare billing of $206,452. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cordova, TN
- Active Since 08/28/2016
- Last Updated 11/13/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1013463223
Products in Payments
- Intracept (Device) $866.75
- Senza (Device) $387.04
- Belbuca (Drug) $343.58
- XTAMPZA (Drug) $342.96
- INTELLIS ADAPTIVESTIM (Device) $160.81
- PROCLAIM (Device) $154.41
- Omnia (Device) $129.67
- SPRINT PNS System (Device) $89.20
- RELISTOR (Drug) $82.09
- QUTENZA (Drug) $67.96
- ROXYBOND (Drug) $66.02
- Aimovig (Biological) $43.48
- UBRELVY (Drug) $41.98
- ZTLido (Drug) $38.15
- EMGALITY (Drug) $35.11
- QULIPTA (Drug) $32.73
- Seglentis (Drug) $23.71
- Roxybond (Drug) $23.66
- General - Pain Management (Device) $23.17
- MOUNJARO (Drug) $13.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cordova
Laura Porch, Fnp, FNP
Family — Payments: $112,526
Family $112,526
Charles Mason, Fnp, FNP
Family — Payments: $14,282
Family $14,282
Jennifer Carmichael
Family — Payments: $6,575
Family $6,575
Jason Stewart, Fnp, FNP
Family — Payments: $6,056
Family $6,056
Rebecca Jones, Aprn, APRN
Family — Payments: $5,359
Family $5,359
Katherine Perkins, Aprn, APRN
Family — Payments: $4,193
Family $4,193